Clinical effects of biapenem on febrile neutropenia in patients with hematological malignancy

Japanese Journal of Antibiotics

Volumn 61, Issue 3, 2008, Pages 115-121

  Kasahara, Senji ^a   Hara, Takeshi ^a   Tsurumi, Hisashi ^a   Goto, Naoe ^a   Kanemura, Nobuhiro ^a   Yoshikawa, Takeshi ^b   Yamada, Toshiki ^a   Sawada, Michio ^c   Takahashi, Takeshi ^b   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Gifu Municipal Hospital

^c Gifu Red Cross Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIAPENEM; CEFTAZIDIME; GENTAMICIN; IMIPENEM; MEROPENEM; OFLOXACIN; ANTIINFECTIVE AGENT; THIENAMYCIN DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENTEROCOCCUS AVIUM; FEBRILE NEUTROPENIA; HUMAN; INFORMED CONSENT; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIPLE MYELOMA; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; TREATMENT RESPONSE; AGED; FEMALE; FEVER; INTRAVENOUS DRUG ADMINISTRATION; LYMPHATIC LEUKEMIA; MALE; MIDDLE AGED; NEUTROPENIA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; FEMALE; FEVER; HUMANS; INJECTIONS, INTRAVENOUS; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEUTROPENIA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; THIENAMYCINS;

EID: 54449090496     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. HUGHES, W. T.; D. ARMSTRONG, G. P. BODEY, et al.: 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 34: 730-751, 2002
2. Japanese source
3. YOSHIDA, M.: Infections in patients with hematological diseases: Recent advances in serological diagnosis and empiric therapy. Int. J. Hematol. 66: 279-289, 1997
4. TAMURA, K.; H. MATSUOKA, J. TSUKADA, et al.: Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study. Am. J. Hematol. 71: 248-255, 2002
5. KLASTERSKY, J. A.: Use of imipenem as empirical treatment of febrile neutropenia. Int. J. Antimicrobial. Agents 21: 393-402, 2003
6. TAMURA, K.; K. IMAJO, N. AKIYAMA, et al.: Randomized trial of cefepime in combination with amikacin as empirical therapy for febrile neutropenia. Clin. Infect. Dis. 39 (Suppl. 1): S15-S24, 2004
7. PERRY, C. M. & T. IBBOTSON: Biapenem. Drugs 62: 2221-2234, 2002
8. Japanese source
9. Jpn. J. Antibiotics 58: 382-387, 2005
10. Japanese source
11. Jpn. J. Antibiotics 49: 1049-1061, 1996